Samsung Bioepis Biosimilar to Roche ' s Herceptin Wins FDA Nod Samsung Bioepis Biosimilar to Roche ' s Herceptin Wins FDA Nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG ' s blockbuster breast cancer treatment, Herceptin.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news